Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.

[1]  A. Arıboğan,et al.  Anesthesia management and sugammadex experience in a neonate for Galen vein aneurysm. , 2016, Journal of clinical anesthesia.

[2]  H. D. de Boer,et al.  The use of rocuronium and sugammadex in paediatric renal transplantation: Two case reports. , 2016, European journal of anaesthesiology.

[3]  E. Gulec,et al.  The Effect of Intravenous Dexamethasone on Sugammadex Reversal Time in Children Undergoing Adenotonsillectomy , 2016, Anesthesia and analgesia.

[4]  J. Mccormack,et al.  The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex , 2016, Paediatric anaesthesia.

[5]  C. Fernández-Pérez,et al.  A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade , 2015, Anaesthesia.

[6]  S. Oba,et al.  Sugammadex versus neostigmina em pacientes pediátricos: estudo prospectivo e randomizado , 2014 .

[7]  S. Oba,et al.  [Sugammadex versus neostigmine in pediatric patients: a prospective randomized study]. , 2014, Revista brasileira de anestesiologia.

[8]  A. Pickard,et al.  The effect of rocuronium and sugammadex on neuromuscular blockade in a child with congenital myotonic dystrophy type 1 , 2013, Paediatric anaesthesia.

[9]  Sinem Sari,et al.  Pediatrik hastalarda sugammadeks kullanımının yan etkileri , 2013 .

[10]  V. Sonzogni,et al.  Efficacy and safety of a sugammadex dose of 4 mg/kg in early reversal of a deep neuromuscular block rocuronium-induced in infants and children: a case series: 10AP2-10 , 2013 .

[11]  Sinem Sari,et al.  Side effects of sugammadex use in pediatric patients Pediatrik hastalarda sugammadeks kullaniminin yan etkileri , 2013 .

[12]  Matinyan Nv,et al.  Sugammadex use experience in pediatric oncology , 2013 .

[13]  N. Matinyan,et al.  [Sugammadex use experience in pediatric oncology]. , 2013, Anesteziologiia i reanimatologiia.

[14]  D. Schwartz,et al.  Caudal block in a child with a sacral dimple utilizing ultrasonography , 2011, Paediatric anaesthesia.

[15]  C. Buchanan,et al.  Case report: sugammadex used to successfully reverse vecuronium‐induced neuromuscular blockade in a 7‐month‐old infant , 2011, Paediatric anaesthesia.

[16]  O. Meretoja.  Neuromuscular block and current treatment strategies for its reversal in children , 2010, Paediatric anaesthesia.

[17]  R. Mirakhur.  Sugammadex in clinical practice , 2009, Anaesthesia.

[18]  B. Plaud,et al.  Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients , 2009, Anesthesiology.

[19]  A. Bom,et al.  Reversal of Neuromuscular Blockade and Simultaneous Increase in Plasma Rocuronium Concentration after the Intravenous Infusion of the Novel Reversal Agent Org 25969 , 2003, Anesthesiology.

[20]  J. Hunter,et al.  Selecting Neuromuscular-Blocking Drugs for Elderly Patients , 2003, Drugs & aging.

[21]  Mark Bradley,et al.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. , 2002, Angewandte Chemie.

[22]  B. Brandom,et al.  Neuromuscular blocking drugs in infants and children. , 1988, Pediatric clinics of North America.